U.S. federal trademark · Serial No. 99119821
Medical research services in the field of cancer treatment; providing medical research information, namely, using artificial intelligence to predict promoter methylation of the MGMT (O6-methylguanine-DNA methyltransferase ) gene and therapeutic response of cancers to related therapies.
Medical analysis of genomic and transcriptomic data using artificial intelligence to predict promoter methylation of the MGMT (O6-methylguanine-DNA methyltransferase ) gene and therapeutic response of cancers to related therapies.
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.